Science Explorer Back to mapMap
Discussion
Researcher · Affimed Therapeutics (Germany) · Germany

Kristina Ellwanger

Kristina Ellwanger publishes mostly in Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Immune Cell Function and Interaction.

OpenAlex
World rank
#1,256,786
of 7,710,434 ranked researchers
Rank in Germany
#61,932
of 364,343
Works
56
Citations
1.3k
Citations per work
23.1
h-index
16
i10-index 18Top 33% in Oncology
Kristina Ellwanger

What does Kristina Ellwanger research?

Kristina Ellwanger's work is mostly in Medicine (55%), Biochemistry, Genetics and Molecular Biology (22%), Immunology and Microbiology (12%).

Health Sciences: 31 works · 54.9% of their workMedicine: 31 works · 54.9% of their workOncology: 14 works · 25.7% of their workRadiology, Nuclear Medicine and Imaging: 14 works · 24.3% of their workHematology: 3 works · 4.9% of their workLife Sciences: 19 works · 34.1% of their workBiochemistry, Genetics and Molecular Biology: 12 works · 21.6% of their workMolecular Biology: 11 works · 18.8% of their workBiotechnology: 2 works · 2.8% of their workImmunology and Microbiology: 7 works · 12.5% of their workImmunology: 7 works · 12.5% of their workEverything else: 6 works · 11.0% of their workTHEIR WORKKristinaEllwanger56works
Life Sciences34%Health Sciences55%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3154.9%
    1. Biochemistry, Genetics and Molecular Biology1221.6%
    2. Immunology and Microbiology712.5%
  3. Everything else611.0%
  1. 1Oncology26% of their works
  2. 2Radiology, Nuclear Medicine and Imaging24% of their works
  3. 3Molecular Biology19% of their works
  4. 4Immunology12% of their works
  5. 5Hematology5% of their works
  6. 6Biotechnology3% of their works

Research topics

Which keywords describe Kristina Ellwanger's research?

The keywords of their largest research topics: Glycosylation, Cancer Immunotherapy, Fc Receptors, Immunotherapy, Therapeutic Antibodies, Tumor Regression, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Glycosylation382 topics
  2. Cancer Immunotherapy342 topics
  3. Fc Receptors321 topic
  4. Immunotherapy322 topics
  5. Therapeutic Antibodies321 topic
  6. Tumor Regression322 topics
  7. CAR T Cells281 topic
  8. Chimeric Antigen Receptor281 topic
  9. NK Cell Recognition91 topic
  10. Natural Killer Cells91 topic
  11. Cancer61 topic
  12. Dendritic Cells61 topic
  13. Diagnosis Criteria61 topic
  14. Glycans61 topic
  15. Immunity61 topic
  16. International Myeloma Working Group61 topic
  17. Breast Cancer51 topic
  18. HER251 topic
  19. Bacterial Therapy41 topic
  20. Tumor Targeting41 topic

Where does Kristina Ellwanger work?

Kristina Ellwanger's main affiliation in the publication record is Affimed Therapeutics (Germany), Germany.

How many publications and citations does Kristina Ellwanger have?

OpenAlex counts 56 works and 1,293 citations for Kristina Ellwanger, an h-index of 16, ranking #1,256,786 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kristina Ellwanger. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.